Statewide Biobank Seminar Series – Dr Louise Winteringham

Share this:

Don’t miss this NSW Health Statewide Biobank seminar with Phenomics Australia Scientific Director Dr Louise Winteringham from Harry Perkins Institute of Medical Research!

➡ Biobanking: are we there yet?

History of biobanking in Western Australia, progress & challenges to developing a statewide biobanking initiative

➡ Wed 08 Nov 2023 12 noon-1 pm AEST

➡ Free registration, all welcome!

About this event

Dr Louise Winteringham will discuss the rich history of biobanking in Western Australia as well as outline progress and challenges to developing a State-wide biobanking initiative. She will present the aspirational goals of the Perkins Cancer Biobank from sample collection to data stewardship and translation. Finally will look ahead to the potential of biobanking in Australia.

About Dr Louise Winteringham:

Louise is a cancer biologist with more than 25 years’ experience in molecular biochemistry and gene regulation in normal and cancer conditions. She currently leads the Translational Cancer Research Program at the Harry Perkins Institute of Medical Research and is the Manager of the Liver Cancer Collaborative. Dr Winteringham established and heads the Perkins Cancer Biobank working with a multidisciplinary team to facilitate collection, processing and analysis of tumour samples. Within the biobank framework, she is co-ordinating the development of a customised secure digital environment to integrate research data with detailed patient information driving a precision medicine approach to oncology. Under her leadership, the Perkins has successfully established immune-humanised mice using CD34+ cells from cord blood to investigate immunotherapy drug response in combination with novel cancer treatments. She also oversees the production of PDX models from several cancers including sarcoma, liver, head and neck, and breast cancer. Dr Winteringham is also Director of the NCRIS Phenomics Australia Perkins Node within our In vitro Capability. This capability is currently developing a National non-animal technology arm that will focus on organoid development and drug screening. She has been a member of the Phenomics Australia Scientific Leadership Committee since 2013.

Dr Louise Winteringham

“Phenomics Australia provides an extraordinary opportunity for researchers to access the latest expertise and technology in functional genomics to advance our scientific knowledge and drive better health outcomes.”

Phenomics Australia Feedback Form

Phenomics Australia (formerly the Australian Phenomics Network, APN) offers consolidated infrastructure and expertise supporting genomic medicine and biomedical research from discovery through into early clinical development and evaluation.

Phenomics Australia is a founding capability enabled by the National Collaborative Research Infrastructure Strategy (NCRIS). We would love to hear from you!

Please feel free to provide any ideas or general comments you might have so that we can further improve how Phenomics Australia can support you.

Phenomics Australia PHENOMENA News Contribution

Have you recently had a publication accepted? Do you want to tell us about a grant you have received? Or maybe you have just been recently in the news? You can complete this form to tell us about your latest research developments.

Information provided will be used to inform press releases, website stories, social media content and more. This form is being used to capture everything that is happening at Phenomics Australia, which can then be used as part of our outreach and communications.

Once you have completed the form, the Communications and Outreach Coordinator will then be in contact with you.


Make an Enquiry

_Get in touch to discuss how we can help with your research.